Of the three protein markers, IL-1β and IL-8 showed increased levels in OSCC patients compared to controls and therefore, could distinguish between cancer and control subjects as single markers but were strongly discriminatory, especially in case of stage III-IV as compared to control subjects, with p < 0.05. This evidence concerns the gene IL1B and cancer.